Category: Axsome
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18
•
Article content NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. announced… (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will report its fourth-quarter and full-year 2024 financial results on Tuesday, February 18, 2025,…